To figure out the roles of IL-8 and STC1 for the educated BM-MSCs driving GC metastasis, neutralizing antibodies were separately or simultaneously used to block IL-8 and STC1 signaling of the BM-MSC-CM harvested after CD44-enriched AGS-sEV treatment. This evidence concerns the gene STC1 and gastric cancer.